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and angiographic variables identified 4 prognostically significant variables:
prior history of Ml (p= 0.04), any significant graft disease =-50%stenosis (p
=0.01), ?1 reversible SPECTdefacf (p =0.005) and EF < 50% (P= O.0003).
The Kaplan-Meier survival curve describes patient outcomes over 4 yeare (p
= 0.04 in pts with 21 reversible defect).
Corrc/usion.’Sestamibi myocardial SPECT has important predictive value
for cardiac event-free survival in CABG patients.
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768-3 Value of Myocardial Perfusion Tomography in the
Aaseesment of Post-Stenting Coronary Restenosis
A.A. Petrekian, A. Ahmad, S.M. Badruddin, Z.-X. He, N.M. Lakkis,
J.J. Mahmarian, M.S. Verani. Bay/or Co//egeofkfedicirre, Houston, TX, USA
There are limited data on the value of single photon emission computed
tomography (SPECT) myocardial perfusion imaging in the evaluation of
coronary stenting and detection of post-stenting restenosis. Accordingly, we
studied 109 consecutive patients (pts) (mean age 60 yeare, 80 males), who
underwent coronary artery stenting (single vessel [n= 100], 2 vessel stenting
[n= 9], primary stenting [n = 76], threatened closure [n = 33]) followed by a
SPECT study during the follow-up period (mean = 122 days). Pts with pre-
vious coronav bypass graft surgery were excluded. Fifty-three pts (46.6%)
had normal follow-up SPECTimaging, whereas 56 (51.4%) pts had abnormal
SPECT studies, of whom 20 had a defect ascribed to a non-stentad artery
and 36 pts had a defect involving the vascular territory of the stentad vessel.
Therefore, a total of 73 (53 + 20) of the 109 (66.9%) pts had no defect in
the vaacularterritory of the stented artery on subsequent SPECT. Follow-up
coronary angiography was performed in 46 pts within 30 days of the SPECT
study.The sensitivity, specificity, positive predictive v@e, negative predictive
value and overall accuracy of SPECT myocardial parfusion imaging to detect
post-stenting restenosis were 85%, 66%, 81Y0,69%, and 85%, respectively.
Twenty-four pts had a SPECT study before and after stenting. The mean
pre-stent defect size was 16.4%, which decreased to 6.7% after stent place-
ment (p = 0.0067). Thus, these date document the value of SPECT in: (1)
assessing improvement in myocardial perfusion after coronary stenting; (2)
detecting Coronav restenosis in stented arteries.
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-~ SpECTMYo~ardial perfusion lma9in9 inpatienta
Who Have Undergone Coronary Artery Stenting
J.J. Milavetz, T.D. Miller, D.O. Hedge, D.R. Holmes, R.J. Gibbons. Mayo
Clinic, Rochestec MN, USA
The role of SPECT myocardial perfusion imaging in predicting stent resteno-
sis is not yet defined. Between April 1991 and April 1996,210 pts at our insti-
tution underwent stress Thallium-201 or Technetium-99m sestamibi SPECT
perfusion imaging following coronaty stent placement. The median duration
from stent placement to SPECT imaging was 95 days (25% and 75% quar-
tiles were 28 and 264 days). Forty-one of these pts had no intewening events
(infarcfiorVCABG) between the stent and SPECT scan and underwent sub-
sequent coronay angiography within 3 months. The median duration from
SPECT imaging to angiography was 6 days (25% and 75Y0quartiles were
1 and 49 days, respectively). Stent location was: 37% LAD; 21% circum-
flex, 30% right coronary artery; 10% vein grafts; 2% left main. Two patients
had stenta in 2 different corona~ distributions. The angiographic definition
of restenosis was 5094 Iuminal narrowing. A positive SPECT study was de-
fined as redistribution in the stent-relatad coronary artery territoy Results by
coronary artery distributions were:
SPFCT+ SPECT–
Angiographicrestenosis 29 2
Noangiogrsphicrestenosis 2 10
The sensitivity of SPECT imaging to identify restenosis was 94%, speci-
ficity 83Y0,positive predictive value 93%, and negative predictive value 837..
SPECT myocardial perfusion imaging is accurate for identifying restenosis
in patients who have undergone coronary artery stenting.
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m7685 Quantitative Adenosine Thallium-201 Single PhotonTomography Accurately Predicts Risk Following
Acute Myocardial Infarction: The Rasults of a
Prospective Trial
H.A. Dakik, J.A. Farmer, Z.-X. He, J.A. Wendt, C.M. Pratt, M.S. Verani,
LA. Mikati, J.J. Mahmarian. 6ay/or Co//ege ofhfedicirre, Houston, TX, USA
We have previously shown in a retrospective study that adenosine tomog-
raphy (SPECT) early after Ml can predict subsequent cardiac risk.* Accord-
ingly, from 02/95 to 06/96, we prospectively evaluated 167 pts admitted to
our county hoapital with acute Ml, of whom 133 (80%) had SPECT within
4.5 * 3.3. days of Ml. Patient risk was based on the total and ischemic (1)
perfusion defect size (PDS): low risk - Group 1 (N = 44; PDS < 20% LV);
high risk – Group 2A (N = 42) and 2B (N = 18) (PDS z 20%, I PDS > 10%
LV); intermediate risk - Group 3 (N = 24; PDS ? 20%, I PDS s 10% LV).
Group 2A had intensive anti-ischemic therapy followed by repeat SPECT
whereas 2B pts either refused corona~ angiography or were not amenable
to revascularization. Mean follow-up was 8.0& 4.9 months.
TotalPDS I PDS LVEF Observed Predicted*
(%)
.3.2* 3.8 :H 11%
(%) Event Rate Event Rate
GrOUD1 7.5 & 5.7 19.L
Group2A
!-,.
37* 13 21 k 10 46& 10 17% 43%
Group2B 47& 16 25+ 11 37 i 12 720/n 55%
Group3 36& 14 4+3 36* 10 29”/o 22%
On repeat SPECT following therapy, Group 2A significantly reduced their
total and I PDS to 23 * 17Y0and 8 l 9%, respectively; thereby decreasing
the calculated predicted event rate from 43% to 20Y0- similar to the 17Y0
observed rate. Cone/usiorr:This prospective study demonstrates that adeno-
sine SPECT can accurately define initial risk after Ml and track changes in
risk following therapy.
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1768-61 AdenosineSPECTin Patients Without Known
Coronary Artery Disease: Prediction of Cardiac
Events And Teet Utilization
A.M. Amanullah, R. Hachamovitch, J. Friedman, H. Kiat, M. Harris,
D.S. Berman. Cedars-Sinai Medical Ctc LA., CA, USA
Little is known regardingthe prognostic implications of pharmacologic SPECT
in patients (pts) without CAD. Thus, we studied 582 consecutive pts without
history of prior Ml, catheterization (cath) or revascularization (revasc) who
underwent dual isotope myocardial perfusion SPECT (rest T1-201/adenosine
Tc-99m sestamibi) (DIMPS). 40 pta were lost to follow-up (F/U) and the
remaining 542 pts (age: 69 + 12 yrs) were F/U for a mean of 28 * 9 months
for hard events (HE) [nonfatal Ml or cardiac death (CD)] and referral to early
cath. DIMPS was visually assessed using 20 SPECT segments and a 5
point scoring system (O= normal, 4 = absent uptake) from which summed
stress score (SSS), summed rest score and summed reversibility score were
calculated. 33 pts had early revasc and were censored from prognostic
analysis. Stepwise Cox proportional hazards model ahowed that SSS addad
significant further information after “forcing in” prescan variables (X2 = 35,
gain in X2, p< 0.001). Rates of CD, Ml and referral to early cath according
to SSS subgroups:
Sss <4 Sss 4-a SSS>8
CD 1.3”/0(4/296) 0.9°A (1/113) 20%(20/loo)t
Ml 1.3”/0(4/296) 4“/. (5/113) 7“A (7/100)”
Early cath 1.7% (5/300) 4,2”/o(5/119) 19.5”/. (24/123)t
tp <0,0001 VS. SW, <4 and SSS 4-S; *p <0.005 vs. SSS <4.
Conclusions: Adenosine DIMPS add incremental prognostic value and
risk stratifies pts without known CAD. Referral rates to early cath in severely
abnormal DIMPS were lower than those reported for exercise stress.
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Endothelial Nitric Oxide Synthase to Rabbit Carotid
Artaries Alters Vascular Reactivity
LJ. Kullo, G. Mozes, R.S. Schwartz, P.Gloviczki, T.B. Croffy, 2.S. Katusic,
T. O’Brian. Mayo Clinic and Foundation, Rochester, MN, USA
Adventitial gene transfer may serve as a tool to study vascular biology
and also have therapeutic potential. We investigated the hypothesis that
adenoviral-mediated transfer of the gene for endothelial nitric oxide synthase
(eNOS)totheadventitia would altervascularreactivity. Rabbit carotid arteries
were surgically isolated and adenoviral vectonsencoding eNOS (AdeNOS) or
